Navigation Links
Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent
Date:3/10/2008

mpared to TAXUS for lesions in a reference vessel

diameter less than 2.5 mm.

XIENCE V was launched in Europe and other international markets in late 2006.

XIENCE V is an investigational device in the United States and Japan, and is currently under review for approval by the U.S. Food and Drug Administration.

Abbott also supplies a private-label version of XIENCE V to Boston Scientific called the PROMUS(TM) Everolimus-Eluting Coronary Stent System. PROMUS is designed, studied and manufactured by Abbott and supplied as part of a distribution agreement between the two companies.

About Abbott Vascular

Abbott Vascular, a division of Abbott, is one of the world's leading vascular care businesses. Abbott Vascular is uniquely focused on advancing the treatment of vascular disease and improving patient care by combining the latest medical device innovations with world-class pharmaceuticals, investing in research and development, and advancing medicine through training and education. Headquartered in Northern California, Abbott Vascular offers a comprehensive portfolio of vessel closure, endovascular and coronary products that are recognized internationally for their safety and effectiveness in treating patients with vascular disease.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com.


'/>"/>
SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Abbott, Genentech and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs
2. Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis
3. Abbott Announces 10.8 Percent Increase in Quarterly Dividend
4. On Valentines Day, Abbott Urges Women to Take Heart With Launch of Faces of Heart Disease Exhibit to Raise Heart Health Awareness
5. Abbott Goes Red to Educate Bay Area Women About Heart Disease
6. Abbott to Present at Merrill Lynch Healthcare Conference
7. Abbotts Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA
8. Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2007 Earnings
9. Cookie Johnson and Abbott Bring I Stand With Magic: Campaign to End Black AIDS to Los Angeles to Educate African-American Women on HIV/AIDS
10. Ugandan Children Are Among the First to Receive Abbotts Lower-Strength Aluvia (lopinavir/ritonavir) Tablet
11. The Magic Johnson Foundation and Abbott Expand Focus of Campaign to End Black AIDS to African-American Women in 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...TSX: COM, VANCOUVER, July 23 /PRNewswire-FirstCal... today announced that it has entered into an,agree...ment fund managed by,CR Intrinsic Investors, LLC, ...rchase Series A convertible preferred shares for g...nancing will be used for general corporate,purpose...
(Date:7/23/2008)...ce the idea of using DNA to create faster, smaller...scientists have been scrambling to develop success... new research from a professor at Rensselaer Polyt... out artificial computations, all we have to do is... Cognitive Science Mark Changizi has begun to deve...
(Date:7/23/2008)..., July 23 /PRNewswire-USNewswire/ -- The Children,...e a generous $15 million,gift that will enable the...own, Pennsylvania. This gift, made possible by Ath...is one of the largest in the history of,Children,s...milies in the,nearby communities convenient access...
(Date:7/23/2008)...ly 23 /PRNewswire/ -- Times may be tough, but,Holl...there,s nothing like,a dazzling new smile to boost...DDS helps his celebrity clients beam in on success...ngs with it the self-confidence they,need for star...ting a new,high-wattage smile designed by Dr. Kosd...
Breaking Medicine News(10 mins):Health News:Cardiome Announces Preferred Share Financing 2Health News:Cardiome Announces Preferred Share Financing 3Health News:Study suggests human visual system could make powerful computer 2Health News:Study suggests human visual system could make powerful computer 3Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 2Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 3Health News:Rock The Cradle's Bad Boy Landon Brown Owes His Irresistible New Smile to Dr. Michael Kosdon 2
...ging that can detect gastrointestinal cancers with...ethods can be soon availed by residents in Delhi. ...visualization of the internal organs through a tel...s). Direct visualization of the internal regions o...
...amination of fluid filled plastic teething ring, m...., parents have been urged by the Food and Drug Ad...h the product. The contaminated liquid if swallow...ral cavity, could lead to sickness. Malnourished i...
...rsity Medical Center have found that the lethal im...than anticipated. Researchers from the Mailman Sch...ter also collaborated in this study, which// appea...e. "Our research illustrates that programs to prev...
... new reasons and factors responsible for unhealthy...me from soft drink incentives, and parents who bri...This new information may be useful to school welln...oping wellness policies as mandated by the Child N...
Other Medicine News:Health News:Gum Disease Affects Diabetic Children Earlier Than Anticipated 2Health News:The trident of unhealthy teen choices is early Lunch, Soft Drink Machine Income and Parents who relent 2
(Date:7/23/2008)... ASPS Study Finds Some Areas of the Body Have G...IGHTS, Ill., July 23 /PRNewswire-USNewswire/ -- Fa...hrough liposuction was found to be,an excellent so...ations,than other areas of the body, reports a Bra...ructive Surgery(R), the official medical journal o...
(Date:7/23/2008)... SEATTLE, July 23 /- Den... that it expects the Independent Data,Monitoring C...rim analysis,of overall survival relating to the C...e AdenoCarcinoma Treatment, also known as D9902B) ...ENGE is the Company,s investigational,active cellu...
(Date:7/22/2008)... BRISBANE, Australia, July 22 /PRNewswire-First...d late yesterday, the Board of Progen,Pharmaceutic...ed that it,had discontinued the PI-88 phase 3 stud...direction to develop its existing portfolio of com...re additional compounds and,opportunities through ...
(Date:7/22/2008)... MINNEAPOLIS, July 22 /- Nonin Med...ing solutions for more than 20 years, has entered,...echnology to measure,regional oxygen saturation. T... is the continuous monitoring of the regional bloo... Early testing data and outcomes from an ongoing c...
Breaking Medicine Technology:Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2MEDdevice Acquisition Co LLC and Epsilon Securities LLC Identify Sources of Funding 21481 1MEDdevice Acquisition Co LLC and Epsilon Securities LLC Identify Sources of Funding 21481 2The Glazier Group Removes Tomatoes from Menus Nationwide 21478 1The Glazier Group Removes Tomatoes from Menus Nationwide 21478 2Oncolytics Biotech Inc Announces Start of Enrolment in Phase 1 2 Ovarian Cancer Clinical Trial with REOLYSIN 28R 29 5914 1Oncolytics Biotech Inc Announces Start of Enrolment in Phase 1 2 Ovarian Cancer Clinical Trial with REOLYSIN 28R 29 5914 2Oncolytics Biotech Inc Announces Start of Enrolment in Phase 1 2 Ovarian Cancer Clinical Trial with REOLYSIN 28R 29 5914 3Miltenyi Biotec GmbH Acquires Medic Tools AG 5911 1Miltenyi Biotec GmbH Acquires Medic Tools AG 5911 2
...as been widely used as the gold standard for prost...reversals in recent diagnostic science, a recent s... findings by other researchers have now put the ut...ed, The PSA era is over in the United States, said...author of the study published in the October 2004 ...
... between analog and digital television sets, so, t...oose between analog and digital mammography units,... centers around the country., ,As of late 2003...cleared four digital mammography units for clinica...graphy systems, approved in January 2000 and manuf...
Other Medicine Technology:PSA TestingHow Much is Too Much? 2PSA TestingHow Much is Too Much? 3Digital vs. Analog Mammography 2Digital vs. Analog Mammography 3Digital vs. Analog Mammography 4
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: